SCHEMBL9285162

SCHEMBL9285162

CCc1ccccc1-c1cccc(Cl)c1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.46
CSNK2B P67870 1/20 0.46
CSNK2A1 P68400 1/20 0.46
CSNK2A3 Q8NEV1 1/20 0.46
KDM4E B2RXH2 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
PKM P14618 1/20 0.43
DPP4 P27487 1/20 0.42
P2RX7 Q99572 3/20 0.41
HTR7 P34969 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
S1PR4 O95977 1/20 0.38
NPBWR1 P48145 1/20 0.37
MME P08473 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
HTR1A P08908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21797134 0.85 KDM4E (0.43) KDM4ENPC1RAB9APKMDPP4
SCHEMBL21797135 0.85 KDM4E (0.43) KDM4ENPC1RAB9APKMDPP4
SCHEMBL10978584 0.83 GABRA1 (0.41) KDM4EPKMMAPTKMT2AMEN1
SCHEMBL9287986 0.81 P2RX7 (0.45) KDM4ENPC1RAB9AP2RX7KMT2A
SCHEMBL22590593 0.79 CD274 (0.43) DPP4MAPTKMT2ANPBWR1NPSR1
SCHEMBL9287839 0.79 DPP4 (0.63) CSNK2A2CSNK2BCSNK2A1CSNK2A3DPP4
SCHEMBL9289933 0.78 CSNK2A2 (0.51) CSNK2A2CSNK2BCSNK2A1CSNK2A3DPP4
SCHEMBL19897383 0.77 KDM4E (0.47) KDM4ENPC1RAB9APKMP2RX7
SCHEMBL9284956 0.76 CSNK2A2 (0.49) CSNK2A2CSNK2BCSNK2A1CSNK2A3DPP4
SCHEMBL7671351 0.74 KMT2A (0.40) KDM4EP2RX7MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND SHIONOGI & CO., LTD. (JP) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND BACE1, STS, APP CSNK2A2 682/4885CSNK2B 358/4885CSNK2A1 613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.